beta-2 microglobulin mutants (Avidex)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Namebeta-2 microglobulin mutants (Avidex)

Drug Alias Namebeta-2mm (Avidex)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionImmunomodulators

TargetsUpdating

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

ATC CodeN/A